RIGI and fatty liver disease: In contrast to those in wildtype mice, RIG-I K18A+K146A mice showed abolished hepatic steatosis and cholesterol accumulation following HFD treatment, while K18M + K146M promoted hepatic steatosis (Fig. 6e, f, Additional file 2: Fig. S6g).